AI-generated summary
The authors report a single-blind randomized feasibility trial of DREAMS-START, a six-session non-pharmacological therapy for sleep disturbance in people with dementia, delivered to family carers versus usual care. They found 66% of eligible referrals consented and 88% of the intervention group attended the required sessions, which they report as meeting their feasibility and acceptability thresholds. The authors describe this as a feasibility study, not an efficacy test.
- Participants
- 62
- Who or what was studied
- People with dementia and sleep disturbances and their family carers, recruited from two London memory services and Join Dementia Research
- Limits stated in the abstract
- The study was designed to test feasibility and acceptability rather than effectiveness, so it does not establish whether the therapy improves sleep.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Methods
We conducted a parallel, two-armed, single-blind randomized trial and randomized 2:1 to
Intervention
Treatment as Usual. Eligible participants had dementia and sleep disturbances (scoring ≥4 on one Sleep Disorders Inventory item) and a family carer and were recruited from two London memory services and Join Dementia Research. Participants wore an actiwatch for two weeks pre-randomization. Trained, clinically supervised psychology graduates delivered DREAMS-START to carers randomized to intervention; covering Understanding sleep and dementia; Making a plan (incorporating actiwatch information, light exposure using a light box); Daytime activity and routine; Difficult night-time behaviors; Taking care of your own (carer's) sleep; and What works? Strategies for the future. Carers kept their manual, light box, and relaxation recordings post-intervention. Outcome assessment was masked to allocation. The co-primary outcomes were feasibility (≥50% eligible people consenting to the study) and acceptability (≥75% of intervention group attending ≥4 intervention sessions).
Results
In total, 63out of 95 (66%; 95% CI: 56-76%) eligible referrals consented between 04/08/2016 and 24/03/2017; 62 (65%; 95% CI: 55-75%) were randomized, and 37 out of 42 (88%; 95% CI: 75-96%) adhered to the intervention.
Conclusions
DREAM-START for sleep disorders in dementia is feasible and acceptable.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dementia, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.